In vitro and in vivo activities of QA-241, a new tricyclic quinolone derivative.
The in vitro susceptibilities of 1,310 clinical isolates to QA-241, a novel tricyclic quinolone, were evaluated in comparison with susceptibilities to norfloxacin, ofloxacin, enoxacin, and ciprofloxacin. The MICs of QA-241 for 90% of staphylococci, Enterococcus faecalis isolates, and streptococcal s...
Saved in:
| Published in: | Antimicrob Agents Chemother |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
American Society for Microbiology (ASM)
1989
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC172615/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2679369/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.33.8.1144 |
| Tags: |
No Tags, Be the first to tag this record!
|